Compare CVM to:
Real-Time: 1.28 -0.01 (-0.78%) 2:33pm ET
| Last Trade: | 1.27 |
|---|---|
| Trade Time: | 2:19pm ET |
| Change: | |
| Prev Close: | 1.29 |
| Open: | 1.29 |
| Bid: | N/A |
| Ask: | N/A |
| 1y Target Est: | 1.00 |
| Day's Range: | 1.23 - 1.29 |
|---|---|
| 52wk Range: | 0.14 - 2.10 |
| Volume: | 2,312,899 |
| Avg Vol (3m): | 11,491,300 |
| Market Cap: | 189.93M |
| P/E (ttm): | N/A |
| EPS (ttm): | -0.09 |
| Div & Yield: | N/A (N/A) |
| Tue, Nov 24 | Cel-Sci's History of Disappearing Drugs: BioBuzzat TheStreet.com |
| Mon, Nov 23 | Poniard Finds Cash to Keep Lights On: BioBuzzat TheStreet.com |
| Mon, Nov 23 | Cel-Sci Chairman Sells Stock, Despite Sweetheart Loan Deal: BioBuzzat TheStreet.com |
| Fri, Nov 20 | Biotech Stock Mailbag: FDA Playbookat TheStreet.com |
| Wed, Nov 18 | CEL-SCI Announces Start of First Clinical Study of Investigational LEAPS-H1N1 Treatment for Hospitalized H1N1 Infected Patients at Johns Hopkins University School of MedicinePR Newswire |
| Thu, Nov 12 | Is Amendment of Previously Filed Paperwork a Sign That CEL-SCI is Expecting Something Big?Business Wire |
| Mon, Nov 9 | CEL-SCI Collaborators Present Data Suggesting That LEAPS Technology Has Ability to Modify Immune ResponsePR Newswire |
| Mon, Nov 9 | A Big Upgrade for Rodman & Renshawat Motley Fool |
| Mon, Nov 9 | D.C. Vaccine Conference Attracts Government Policy Makers and Biotech InnovatorsBusiness Wire |
| Fri, Nov 6 | Biotech Stocks: Drug stocks edge higher; Alkermes slidesat MarketWatch |
Quotes delayed, except where indicated otherwise.
Delay times are 15 mins for NASDAQ, NYSE and Amex.See also delay times for other exchanges.